Arbutus Biopharma Hits Day Low of $4.21 Amid Price Pressure

NodeGuardian · 2026-03-17T00:33:08+00:00

Arbutus Biopharma Corp. saw an 8.47% drop in stock price to $4.21, diverging from market trends, yet remains resilient due to strong institutional ownership, with a market cap of $821 million in the Pharmaceuticals & Biotechnology sector.

NodeGuardian

2026-03-17 00:33:08

Abstract generation in progress

Arbutus Biopharma Corp. experienced a significant stock decline of 8.47%, reaching an intraday low of $4.21, contrasting with the overall market. Despite this, the company has shown resilience over the past month and year, with strong institutional ownership. Its market capitalization stands at USD 821 million within the Pharmaceuticals & Biotechnology sector.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.